INHIBITION OF THE LESIONS OF PRIMARY VACCINIA AND OF DELAYED HYPERSENSITIVITY THROUGH IMMUNOLOGICAL TOLERANCE IN RABBITS by Flick, John A. & Pincus, William B.
INHIBITION OF  THE  LESIONS  OF  PRIMARY  VACCINIA AND  OF 
DELAYED  HYPERSENSITIVITY THROUGH IMMUNOLOGICAL 
TOLERANCE  IN RABBITS* 
BY JOHN A. FLICK, M.D., AND W~J.~M B. PINCUS,~ M.D. 
(From lhe Depart~ment of M/crob/o/ogy,  Graduate  School of Medicine, University of 
Pennsyl~ani¢, Philadelphia) 
(Received for publication, December 10, 1962) 
Although the concept, that hypersensitivity plays an important role in the 
development of the lesion of primary local vaccinia, was offered by yon Pirquet 
(1) early in this century, it has been obscured in recent years by greater interest 
in the lytic abilities of the multiplying virus in host cells, especially as observed 
in tissue culture (2-4). 
However, when opposing hypotheses of lesion  formation, i.e.  the  allergic  ~ 
the cytopathic concepts, have been put to test in intact animals, the experimental 
results have favored hypersensitivity over cytoI~thogenicity as basically responsible 
for the  skin lesion.  Thus, in  children  the shortened incubation period of a  second, 
local vaceinial lesion derived from an infection initiated 2 days after a primary inocu- 
lation of vaccinia virus, indicated:that the second infection was not an independent 
event, but rather was influenced by allergy already provoked by the first infection in 
the same host (5). Pincus and Flick (6) also found that a primary vaccinial lesion in 
the guinea pig was completely suppressed by the  local injection  of a  rabbit anti- 
guinea pig mononudear ~  serum. This treatment also prevented the occurrence of 
delayed hypersensitivity to inactivated vaccinia virus as well as other expressions  of 
delayed allergy. 
But before the role of developing hypersensitivity in the production of the vesicular 
lesion of primary vaccinia can be considered  as proven, further evidence supporting 
this concept must be obtained by other, unrelated technics.  Accordingly,  this report 
deals  with  the  suppression  of  the  primary vaccinial lesion  when  delayed  hyper- 
sensitivity to the vacduial antigens is inhibited by another method. The method of 
immunological tolerance was used in newborn rabbits to suppress the development of 
allergy to the vaccinial antigens. This procedure also accomplished  a  suppression of 
the expected local lesion following infection with the active virus. 
The  use  of  microbial  antigens  to  induce  specific  immunological  tolerance  has 
lacked the degree of success associated with tolerance directed toward tissue homo- 
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grafts or toward heterologous  serum proteins. Bumet et aL  (7)  using chickens,  and 
Nossal (8) using mice, were unsuccessful  in establishing tolerance to the antigens of 
influenza virus. Cohn (9), as well as Smith and Bridges (10), failed to induce tolerance 
to a variety of microbial antigens. Festenstein and Bokkenheuser (ll) were unable to 
induce tolerance in rabbits with Treponema pallidura, while Rees and Garbutt (12) 
likewise failed with Myeobacteriura tuberculosis in mice. 
In contrast to these, there have been a number of reports of successful induction 
of tolerance, partial or complete, to microbial products.  In retrospect, Tranb  (13) 
probably encountered the tolerant state with respect to lymphocytic choriomeningitis 
virus  when  injection  occurred  in  some  colonies  of  laboratory mice.  Buxton  (14) 
observed tolerance with respect to Salmonella pullorum infection in chickens.  In a 
small number of calves, Kerr and Robertson (15) observed unresponsiveness  (tolerance 
or paralysis) with respect to Trickomonas foetus  infection.  A dose of about 1 gin of 
antigen  was used  in  their  studies  to render  the  animals tolerant.  Weiss  (16) was 
often able to prevent the development of tuberculin skin hypersensitivity by prepara- 
tive injections into fetal guinea pigs of either tuberculin or killed BCG but not with 
living BCG. Tolerance here was of relatively short duration.  Friedman and  Gaby 
(17)  were able to produce partial  tolerance in  chickens  with  suspensions  of killed 
ShigelIa. Tolerant animals had significantly  lower titers of antibodies after challange 
than the unprepared controls.  However, there was no delay in the antibody response 
in  the  tolerant animals like the delay found by Gowland and  Oakley (18) as the 
sole evidence of tolerance in  chickens  involving diphtheria  toxoid as the antigen. 
They used 10 Lf of toxoid to prepare the animals (about 30 vg, reference 19, of purified 
toxoid protein) and after challenge, 8 of 10  tolerant animals showed a  delay of 4  to 
7  days in  antitoxin  production  as  compared to  the  controls.  Since  no  significant 
depression of antibody level occurred here and a small number of animals was involved, 
only future experience  can decide  if this represents true tolerance.  Relativdy small 
differences in antitoxin titers suggested to Lindorfer and Subr~manyam (20) that they 
had  successfully  produced  tolerance to staphylococcal toxins in rabbits. Sterzl and 
Trnka (21) prepared newborn rabbits with low dose  (108 organisms)  and high dose 
(5  X  109 organisms)  suspensions of Salmonella sckottrauelleri. Both groups of animals 
developed homologous antibodies  shortly thereafter.  But,  upon  challange  about 4 
months later when these antibodies had disappeared from the blood,  only the high 
dose group failed to show a rise in homologous  antibody, suggesting  tolerance.  This 
observation, that the preparative antigen exposure immediately after birth produced 
an antibody response,  is unusual.  But, in spite of this transitory immune response,  a 
state of tolerance seemed to occur later. 
Thus, even with those reports of successful induction of tolerance toward microbial 
antigens, there is considerable  variation in reliability of the effect;  partly because of 
the small animal sample used in some of the experiments and also partly because of 
some of the unduplicated, unique results interpretated as tolerance in other experi- 
ments. Although several investigators have suggested that the degree of "foreignness" 
of an antigen plays an important role in its inability to induce  tolerance in a given 
species of animal (8, 22, 23), in view of the relatively high probability of success with 
some microbial antigens, better explanations of the difficulty  in tolerance induction 
might include  the dosage  effect. The work of Smith and Bridges (10), dealing  with JOHN A. ]~LICK AND WILLIAM B. PINCUS  635 
tolerance against bovine serum albumin as the antigen, emphasizes the importance of 
large doses of antigen in inducing complete tolerance and bringing  about a prolonged 
state of immunological failure. With microbial suspensions especially, a  small total 
mass of organisms represents a much smaller amount of each component antigen of 
which there are usually many. 
Following this lead,  a  relatively large dose  of  inactive vaccinia vires was 
used to prepare our immature animals; 0.5 to 1.0 rag of partially purified virus 
per rabbit. In addition, since the duration of the tolerance state seems to be 
dose-dependent (10), it seemed highly desirable to infect the tolerant-prepared, 
newborn rabbits as soon as possible with active vaccinia virus. These and pos- 
sibly other factors to be considered later, may have increased the chances of 
successfully inducing a  high level of tolerance to vaccinia virus for a period of 
sufficient duration to allow the study of the local disease. 
Materials and Methods 
Active vaccinia virus, in the form of a large batch of commercial calf lymph virus, was ob- 
tained through  the generosity of Dr. M. Z. Bierly of  Wyeth Laboratories, Inc., Marietta, 
Pennsylvania. It was inoculated always by the multiple pressure technic into a depilated ares 
of skin. The preparation had an activity of 106 TCIUs0/ml in monkey kidney cell culture (24). 
Inactive virus for skin testing was prepared by heating the calf lymph vaccine at 600C for 1 
hour. This was tested for the lack of infectivity in tissue culture before use. It was inoculated 
into the skin of the animals in the same manner as the active virus. 
Inactive, purified virus for tolerance preparation was grown in calf embryo  1 epidermal cell 
cultures (25). Approximately 4 days after inoculating the sheet of epidermal cells in each large 
bottle with about l0  t infectious units of virus, the cells were mostly lysed and the fluid was 
harvested. A batch of about 4.6 liters of culture medium was processed to purify the vacciula 
virus therein. The fluid was first centrifuged at 800 m,~ (50 63 for 20 minutes to remove large 
cellular debris, then at 4500 m'M (1600 63 for 2 hours to sediment the vires. This cycle of 
differential centrifugation  (26) was repeated twice, using Hanks' solution to resuspend the 
virus. The purified virus in final suspension was found to contain 10  n.z TCIU60/ml. 20 ml of 
this suspension was lyophili~.ed,  weighed, and the weight of the solids from the Pl,nks' solution 
subtracted. The resulting 18 mg of virus was then resuspended in water to yield a suspension 
contnlnlug 1.0 mg of vims/ml. This weight of the vires must also include some fine cellular 
particles comparable to the vires in size. 
The virus suspension was divided in half, and each half inactivated by a different method; 
one part by means of 00°C for 1 hour and the other by use of 0.2 per cent beta propiolactone 
at 37°C for 1 hour  (27). The 2 aliquotes were recombined. Following inactivation, the virus 
was found to be non-infectious in calf embryo epidermis culture, both undiluted and diluted 
1:1000 in order to reduce the possibility of the interference phenomenon effect masking active 
virus. As further evidence of inactivity of the virus was the absence of evidence of generalized 
vaccinia following  the injection intramuscularly of about 1.0 nag of the virus preparation into 
each of about 40 rabbit fetuses. The use of 2 different methods of inactivation was to improve 
the probability that all native antigens would be present in the final product. 
a We wish to express our thanks and appreciation to Dr. Eugene Rosenoff for permitting 
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In order to improve the chance of having some antigen in a soluble (12) rather than partlcu- 
late form, half of the bulk of inactivated virus was treated in a  10 kc sonic oscillator for ~.~ 
hour and then recombined. Solubilization  of viral antigens is certainly not complete  under these 
circumstances since such treatment  does not appreciably reduce the infectivity of vaccinia 
virus (28, 29). 
Animals  and Preparalion.--Rabbit  fetuses on the 20th to 24th day of gestation were in- 
jected with 1.0 mg of inactivated, purified virus, through the intact uterine wall. Those sur- 
viving the 3rd day postpartum were then inoculated with active vaccinia virus. 
In an attempt to produce tolerance after birth, rabbits were injected intramuscularly with 
0.5 mg of inactive, purified virus within 24 hours of birth. A period of 2 days was allowed to 
elapse in order to observe for evidence of acute toxicity of the virus preparation. No adverse 
effects were observed. At the end of this observation period the 8nlroals were vaccinated with 
active virus. 
Control newborn rabbits were those which were not prepared by the injection of inactive 
virus. They were vaccinated with active virus at the same age as the test animals. 
RESULTS 
With all of the animals the timing of the various observations is designated as 
days after the first application of active vaccinia virus, which occurred, then, on 
day zero. 
In order to obtain a  normal baseline of reaction,  15 newborn rabbits were 
inoculated with active vaccinia virus 4  days after birth. Two of the animals 
failed to develop local vaccinial lesions and subsequently failed to give a  re- 
action of local hypersensitivity to inactive virus. These rabbits were not in- 
vestigated further.  But  13  of the  rabbits developed typical,  local  lesions  of 
vaccinia. Papules or vesicles appeared by day 2 and all had vesicular lesions 
by day 3. These became pustular by the 4th day and gradually healed with a 
small scar remaining.  On day 7, they were skin-tested with inactive virus for 
hypersensitivity. By the following day,  11  of the  13 rabbits with lesions had 
reactions of allergy consisting of papules surrounded by erythema. None of the 
control animals showed gross evidence of systemic vaccinia. 
In an attempt to produce immunological tolerance, 22 newborn rabbits de- 
rived from 6 does were given 0.5 mg of inactive, purified vaccinia virus on the 
day following birth by intramuscular injection. Over the next several days of 
observation, these animals appeared normal.  Three of the  animals were not 
treated further but were observed for gross evidence of acute or chronic toxicity 
resulting from the injection of inactive virus. These remained normal in appear- 
ance and behavior. 
The 19 remaining, tolerant-prepared rabbits were vaccinated with active virus 
at 4 days of age (now day zero). On day 1, slight erythema appeared at the 
inoculation sites of 2 rabbits. By day 2, these and 6 more showed a flat small 
area of erythema. There was no evidence of edema at these sites of inoculation in 
any of the rabbits. By day 3 all redness had disappeared, but now 7 rabbits had 
a  small, flat, brown scab covering the site of vaccination. Six of these rabbits ~0HN A. I~LIC~  AND WII~IAM B. PINCUS  637 
were among those with early erythema, but 1 had not shown redness.  Subse- 
quently, as long as the scab persisted, hair failed to grow at the site; although it 
grew profusely elsewhere. The scabs persisted for over 7 days in surviving ani- 
mals but disappeared without scar by the 14th day. At no time did these rabbits 
with scabs have papules, vesicles, or diffuse edema at the inoculation sites. 
The remaining 12 tolerant-prepared, vaccinated rabbits developed no visible 
lesion at the inoculation site at any time during the period of survival. Also, 
none of the test or control animals developed obvious vaccinial lesions of the 
skin at sites distant from the area of inoculation of virus. 
Although the control animals survived the postinfection period without loss, 
such was not the case with the tolerant-prepared rabbits. A high mortality rate 
occurred in this group. All these rabbits, both with and without scabs survived 
through postvaccination day 3, at which time the controls had vesicles. Starting 
on day 4, deaths occurred in both groups of tolerant-prepared rabbits.  By the 
7th day, 11 of the 19 rabbits had died. One other rabbit died on the 10th day, 
and another on the 14th day, leaving 6 survivors for late study (see Fig. 1). 
Evidence of Successful Infection.--Becanse failure of lesion formation in the 
tolerant-prepared rabbits could be due to a failure of infection, it was necessary 
to prove that the vaccinia virus had actually infected the test animals.  Virus 
isolations were attempted on the organs of 4 of the 5 rabbits dying on day 4. At 
autopsy, the liver and lungs of each rabbit were pooled for studies in tissue 
culture. Virus was isolated from all 4 pools, and was proven to be vaccinia by 
specific neutralization with rabbit antivaccinia serum in the second serial pas- 
sage. In addition, the 5th rabbit dying on the 4th day and 2 rabbits dying on the 
5th day were found to have typical vaccinia inclusion bodies in many cells of the 
lungs, liver, and of the epidermis at the site of inoculation. These microscopic 
findings may be interpreted as presumptive evidence of vaccinia infection; since 
in themselves, they are not completely diagnostic of vaccinia rather than some 
other viral infection. 
Hypersensitidty and Serology.--On the 7th day, the 7 surviving tolerant-pre- 
pared rabbits were tested for hypersensitivity  with inactive virus. None of these 
rabbits showed reactions  of allergy on the next and subsequent days at the 
inoculation site. 
Blood was drawn on the llth day from the 6 surviving test rabbits and from 
6 control rabbits. None of the tolerant-prepared rabbits had detectable hemag- 
glutination-lnhibition antibodies. On the other hand, 3 of the 6 newborn control 
rabbits had detectable antibodies with titers of 1:2 to 1:4. 
Patkological Examinations.--All  tolerant-prepared  rabbits  were  autopsied 
shortly after death. Certain gross features were common to all. The lungs ap- 
peared congested  with multiple small  subplenral  hemorrhages.  Visceral pox, 
which often accompanies generalized vaccinia in animals  (30), did not occur in 
the gross in the organs of these animals. 638  II~II"ION  0~  LESIONS 
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Histological sections were prepared from lung, liver, and skin at inoculation 
site of rabbits  dying on the 4th  and 5th day. The lung sections  presented 
thickened alveolar walls, some infiltration of septa by polymorphonuclears  and 
by round cells, and minute areas of hemorrhage. The liver contained microscopic 
areas of necrosis of the parenchymal cells without appreciable inflammatory  re- 
action or loss of cellular architecture. The single skin section  was through a 
scab.  There was loss of a small area of epidermis and the dermis below was 
infiltrated with inflammatory  cells. In all sections, the cells containing inclusion 
bodies (Hotchkis-McMannus stain), did not appear necrotic. Also the necrotic 
areas of liver did not appear to be closely adjacent to cells containing viral in- 
clusions. Sections were not obtained of inoculation sites which failed to produce 
a scab or other lesion. 
Revaccination Studies.--About  1 month after the initial vaccination with 
active virus, some of the control, and all the surviving test rabbits were reinocu- 
lated with virus to determine their immunological status and responsiveness. 
With active virus reinfection, 4 control rabbits developed "immune" responses, 
consisting of papule formation by 24 hours. Inactive virus inoculation in these 
animals produced a similar reaction. Vaccinial antibodies 4 days after revac- 
cination varied in titer from 1: 2 to 1: 8. 
The 6 surviving tolerant-prepared rabbits behaved differently upon rechai- 
lenge. Three rabbits died: 1 on the 3rd day and 2 on the 5th day postrevaccina- 
tion. The former rabbit failed to react to either active or inactive virus before 
death. One of the latter animals developed a typical "immune" response at both 
the active and inactive virus sites within the first 24 hour period. The other de- 
veloped a typical "primary" reaction in timing and morphology at the active 
virus site, but no reaction at the inactive virus site prior to its death. The cause 
of death in these animals is unknown. The remaining 3 rabbits survived beyond 
the 5 day period of observation without developing evidence of inflammation  at 
either inoculation sites. Thus, 4 of 6 tolerant-prepared rabbits failed to react 
locally to the virus upon reexposure. 
In  Utero Tolerant-Prepared Rabbits.--Relatively little information was ob- 
tained from this group because of short survival times. Of 40 rabbit fetuses in- 
jected with 1.0 mg of inactive purified vaccinia virus 1 to 2 weeks before birth, 
only 8 survived the 3rd postnatal day, at which time they were vaccinated with 
active virus. At 24 hours, 4 rabbits had slight erythema without edema at the 
inoculation site. This redness persisted to the 2nd day in 3 of the 4 rabbits and 
appeared in a 5th rabbit on this day for the first time. On the 3rd day, 7 animals 
were found dead. The 8th rabbit was dead on the 4th day. None of the animals 
had developed evidence of edema or vesiculation at the inoculation sites before 
death whereas the controls usually had typical lesions by this day. Virus isola- 
tion was attempted on 4 of the 7 animals dead by the 3rd day. Again, pools were 
made of the liver and lungs from each animal; but in addition, in 2 cases, the 640  INkUBITION  O]~ LESIONS 
skin of the inoculation site was included in the pool. Vaccinia vires, as proven by 
specific neutralization, was isolated in tissue culture from 3 of the 4 animals. 
The other 3 animals of this group were studied histologically. The gross and 
microscopic findings were like those described for the postnatal, tolerant pre- 
pared animals. Again, inclusion bodies compatible in appearance with vaccinial 
inclusions were observed in the organ sections. 
DISCUSSION 
Those rabbits,  which were tolerant-prepared postnatally, lived sufficientiy 
long after active virus inoculation to insure a  failure of development of the 
typical local vaccinial lesion. Those rabbits,  which were prenatally tolerant- 
prepared, did not survive sufficiently long after viral infection to lend certainty 
to lesion failure, but were suggestive of the same trend. In contrast the control 
animals developed vaccinial lesions within 2 days after infection. Therefore, 
tolerance preparation seemed to be responsible for the local lesion failure. In 
addition, tolerance preparation was associated with a failure of the animals to 
develop delayed hypersensitivity to the vaccinia viral antigens. This was most 
evident after the first challenge of the postnatally prepared animals, but was 
still evident in 66 per cent of the survivors when rechallenged with active and 
inactive virus 1 month later. The lack of an "immune" response to active virus 
in many of these animals especially emphasizes the failure of hypersensitivity 
production against vaccinial antigens. The ability to isolate vaccinia virus from 
the organs of the test animals, and to a lesser degree, the finding of viral in- 
clusions, presumably vaccinia, in organ sections of some animals, indicates that 
viral multiplication occurred in these rabbits. Therefore, the lack of a  typical 
local vaccinia lesion is not due to failure to infect the animals. Rather, the evi- 
dence points to the inability to produce vaccinial hypersensitivity as the prob- 
able cause of lesion failure. The evidence incriminating hypersensitivity does 
not depend upon the mechanism of immunological tolerance for the effect ob- 
tained. Rather, the method of immunological tolerance was used in an attempt 
to suppress hypersensitivity formation to vaccinia antigens. The mechanism of 
such  suppression is speculative at  the present  time.  It is the association of 
lesion  failure with  immunological failure  that  points  to  the  mechanism  of 
pathogenesis of the lesion here. 
Support for the allergic hypothesis of formation of the primary local vaccinial lesion 
comes not only from the evidence presented here, the evidence previously cited in the 
introduction concerning humans (5)  and guinea pigs  (6)  investigated  by different 
technics, but also from other types of experiments. Thus, Pincus and Flick (31) have 
found that x-irradiation  of guinea pigs in doses as high as 1000 roentgen  failed to 
prevent the occurrence of the primary vaccinial lesion and also to prevent the rapid 
development of hypersensitivity to vaecinlal antigens. This too supports the hyper- 
sensitivity concept in association with other evidence cited, in that even high doses JOHN A.  FLICK  AND WILLIAM B.  PINCUS  541 
(32) of x-ray failed to inhibit both the allergy development and the appearance of the 
vaccinia lesion. In still another direction Ledingham (33)  found, and Widelock (34) 
confirmed that the local injection of India ink before or during vaccinia virus inocu- 
lation inhibited the appearance of the local vaccinia lesion. Ledingham also found that 
local India ink injection inhibited the reaction of allergy to vaccinia virus in infected 
animals. However, the ink injection did not interfere with local virus multiplication 
at the site of injection (34). 
On the other hand, Baron et al.  (35)  found that guinea pigs treated with 300 r  of 
x-irradiation  and  the  leukocyte  suppressive  drug,  methotrexate,  developed  local 
primary vaccinia lesions but failed to show evidence of delayed hypersensitivity. This 
evidence better supports the cytopathic concept of lesion development, or, some non- 
allergic hypothesis.  Our observations with vaccinia suggest that, under  certain  con- 
ditions, allergy will develop, but is difficult to demonstrate using inactive virus. But, 
by reinfection with active virus, provided the immunity is not great enough to inhibit 
viral multiplication completely, an accelerated lesion suggestive of a Koch phenomenon 
appears. Thus, the problemhere may well be one of attempting to detect low levels 
of hypersensitivity or even local but not generalized hypersensitivity. 
The development of fiat scabs without edema at the site of inoculation of active 
virus in 7 of 19 tolerant-prepared animals is perplexing. These are certainly not typical 
vaccinial lesions. Nor is this scab lesion produced by a  similar needling of the skin 
through a "drop of normal serum or saline. The scab seems to have covered a  small 
area of epidermal cell loss and beneath this, there is some infiltration of the dermis 
with  inflammatory  ~Als.  Although  virus  inclusions  occurred  in  some  cells  in  this 
region, degenerate or necrotic cells were not obviously present at 4 days after infection. 
Animals with scabs otherwise reacted like animals without scabs in this group. One 
of several mechanisms might  account  for the  scabs.  This lesion  could  represent a 
degree of epidermal cell necrosis due to the cytopathic properties of the virus. If it 
does,  then the majority of tolerant-prepared  animals fail to show gross evidence of 
such  cytopathogenicity,  and  also  other  technics  (6,  31)  useful  in  suppressing  the 
vacoinia lesion are not  associated with scab formation. Rather, it would  seem more 
likely that scab formation is associated with the particular technic reported here and 
used to suppress the immunological responses. 
Another  possible mechanism  of  scabbing  might  involve a  partial  escape of  the 
immunological apparatus from the suppressive effects of the preparative virus antigen 
injection.  Enough  allergy may have developed  to produce  the  scab without  being 
detected by the skin-testing procedure in use. This explanation also seems unlikely to 
us at the moment because of the lack of a vesicular component, the lack of detectable 
edema, and failure of persistence or complete lack of erythema, all so characteristic of 
even weak hypersensitivity reactions. 
A third possible mechanism of formation of the scab could be connected with the 
toxic properties of vaccinia virus (36, 37). This reaction could be akin to the endotoxin 
type of damage caused by Gram-negative bacteria or their active fractions and not 
associated with  the act of viral multiplication.  Sufficient virus  "toxin"  (associated 
with the virus particle) might be produced locally in some animals as a result of un- 
restrained local multiplication when the specific defense mechanisms are completely 
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of immunological responses locally as with the use of an antimononudear cell serum 
(6) or India ink (32) would not prevent some specific immunological forces (antibodies, 
etc.) from entering the area to neutralize the toxic properties. Although we favor this 
third concept, only further detailed investigations can determine the true mechanism. 
Although this study was concerned mainly with the local vaccinial skin lesion,  the 
high mortality rate in both pre- and postnatal, tolerant-prepared rabbits after vaccinia 
infection cannot be ignored. The observations suggest that these animals died from 
generalized vaccinia and perhaps, as a result of the toxic properties of the virus pro- 
during an endotoxin-type of disease.  Thus, other infectious diseases  do not account 
for these deaths.  There was little evidence of other infectious diseases  in the other 
rabbits housed in the unit.  Also control rabbits not prepared for tolerance usually 
remained healthy aside from the local vaccinial lesion.  The isolation of vaccinia virus 
from the organs of some of the animals and the finding of inclusions typical of vaccinia 
virus in the organs of others in the experimental group indicate that a spreading type 
of vaccinial infection had occurred from the site of skin inoculation in the tolerant- 
prepared animals. These two lines of evidence suggest that the deaths were due to 
systemic  vaccinia  infection.  The  gross  and  microscopic  tissue  reactions  of  small 
hemorrhages in the lungs, and of scattered small areas of necrosis seen in the liver are 
at least compatible with the concept of a toxic disease and vaccinia virus has the toxic 
potentials (36, 37) for producing such in vivo damage. The fact that the virus spread 
readily to distant tissues from the local site of infection suggests that an early, probably 
specific,  immune response normally develops to prevent this spread in non-tolerant 
inoculated animals. A similar inhibition of this hypothetical immune response probably 
occurred when adult guinea pigs (31) were infected locally with vaccinia virus following 
a single, lethal (death at 10 to 14 days from the drug alone) dose of the antileukocyte 
drug, vincaleukoblastin  ~ (38). The vaccinated animals died at 3 to 4 days and presented 
the same type of gross and microscopic pathological lesions,  including viral indusions 
in the organs, as the infected tolerant-prepared neonatal rabbits. 
This suggestion of an immunity arising within 2 to 3 days of local vaccinial infection 
at the level of the regional lymph node or even at the site of original infection itself 
is consistent with the observations of McMaster and Kidd (39)  that an antivaccinia 
factor (probably either  antibody or interferon)  can be obtained from the draining 
lymph node as early as 3  days' postinfection.  It is  also consistent with  the  early 
occurrence of delayed hypersensitivity by skin test to vaccinia antigens as observed 
in other studies  (5,  6).  Although we are not attempting to equate here the cellular 
allergic response with a mechanism of viral immunity there is nothing in the vaccinial 
infection observations that is incompatible with this view. 
The methods of immunological tolerance production were used here as a tool rather 
than to elucidate the production of tolerance to a  microbial agent. That some form 
of immunological unresponsiveness was produced by the procedure used seems highly 
likely from the lack of immunological responses to vaccinia by the animals. Whether 
this  state  is  best  described  by the  term,  tolerance,  with  its  implications  of being 
inducible  only in  the  immature  period  of the  young animal  or by immunological 
paralysis which seems to be independent of age (40), cannot be resolved now. Tolerance 
does not require excess antigen to linger in the tissue fluids outside of immunological 
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cells during its existence according  to the cell transfer studies  of Smith and Bridges 
(10). Paralysis (probably a misnomer) may require antigen to be in the tissue fluids 
or adsorbed  to cells in order that antibody may combine with an excess of antigen 
outside of the cell as fast as it is formed (41).  Whatever the detailed mechanism, 
it is evident in our study that newborn rabbits have been made tolerant immuno- 
logically toward the antigens of vaccinia  virus for at least a relatively brief period. 
Perhaps tolerance also explains the early observations of Olitsky and Long (42) made 
on a single pregnant rabbit and its 3 offspring. The mother was infected with vaccinia 
virus during pregnancy. The 3 offspring failed to develop lesions when vaccinated with 
active virus at 32 days (1 rabbit) or 64 days (2 rabbits) of age. One of the latter animals 
had vaccinia virus (derived from the mother before birth) isolated  from its testicles 
1 month before the challenge vaccination. 
SUMMARY 
In order to gain insight into the pathogenesis of the vesicular lesion of local 
primary vaccinia infection, newborn rabbits were injected with 0.5 nag of puri- 
fied inactivated vaccinia virus in an attempt to render them immunologically 
tolerant. Within a few days these, and control normal rabbits of the same age, 
were infected on the skin with active vaccinia virus. Most of the tolerant-pre- 
pared rabbits failed to develop a local lesion of vaccinia but some developed a 
very atypical lesion. Successful virus isolation from some, and the presence of 
inclusions in the tissues of others, indicated successful infection with the virus. 
Skin allergy to the active virus failed to develop in the test animals but did in 
the controls. Thus, there was a high degree of correlation between inability to 
produce delayed hypersensitivity to the viral antigens and failure to develop a 
vaccinial skin lesion,  indicating  the  probable  allergic nature  of the  primary 
lesion. 
There was also a  high mortality rate in the group of tolerant-prepared, in- 
fected animals. It was associated with a spreading of the virus from the site of 
infection to the organs, suggesting that generalized vaccinial infection was the 
cause of death.  The observations were compatible with  the hypothesis that 
death was due to viral toxicity. 
The observations  also  suggest  that,  in  the  animal  possessing  normal  im- 
munological function, active immunity develops rapidly, perhaps at the level of 
the draining lymph node, to prevent appreciable virus from leaving the site of 
infection. 
The absence of detectable immunological activity toward vaccinia virus early 
in the tolerant-prepared animals and even after 1 month in some of the sur- 
vivors, indicates that a  high degree of immunological tolerance was produced 
against these microbial antigens. 
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